Media says it is likely this treatment may address circa 60% of cancers and will enter 2nd phase human trials next year.
All sounds a bit quick and I don't think this is an FDA sanctioned trial rather a locally authorised ( by whom I know not at this stage) Australian trial.
The relationship to CDY and MK detection is a an indeterminate one at this stage however clearly does not replace CDY IP. For instance, would it treat a solid brain tumor by direct injection ?.. I wouldn't know however that would seem a dramatic process.
The media article I viewed was for a melanoma tumor and had pretty dramatic response.
- Forums
- ASX - By Stock
- AN1
- QBiotics v Cellmid
QBiotics v Cellmid, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable